Covid: Brazil allows the resumption of Chinese vaccine trial margin: Calc (0.5rem / 2);

Anvisa suspends trial of the vaccine in Brazil two days ago, citing "serious adverse incident" -. Reported that the death of a volunteer

The director of the Institute of conducting the trial said the death had no connection to the vaccine.

said in a statement on Wednesday, Anvisa said it now had "sufficient information to allow vaccination to resume".

"It is important to clarify that a suspension does not necessarily mean that the product under investigation does not offer the quality, safety or efficacy," he said.

President Jair Bolsonaro earlier declared the suspension of a 'victory'.

It has been long criticized the vaccine because their Chinese ties and said he would not be acquired by their country. He has also participated in a political struggle with the governor of Sao Paulo, João Doria, who has publicly backed the trial.

Mr Bolsonaro has not yet commented on the announcement of the Anvisa that the trial will resume.

The vaccine, developed by the Chinese company Sinovac Biotech, is one of several in late-stage testing worldwide. Sinovac says it is "confident in the safety of the vaccine"

Brazil has been one of the countries most affected by the coronavirus, recording more than 5.6 million cases confirmed -. The third highest figure in the world after the United States and India -. and about 163,000 deaths, according to data compiled by Johns Hopkins why the trial was stopped

On Monday, the Anvisa said it had "ruled that interrupt the clinical trial? the CoronaVac vaccine after a serious untoward incident ".

No revealed what had happened, or where it took place. Css-1pzprxn-BulletListContainermargin-left: 1.5rem; CSS-1pzprxn-BulletListContainer

  • Have we finally got a coronavirus vaccine

    Dimas Covas, director of the Instituto Butantan the realization of? tests, local media that the suspension of judgment is related to a death but insisted that death was not related to the vaccine.

    This was backed by Jean Gorinchteyn, health secretary of the state of Sao Paulo, said in a press conference that the death was an "external event" that was unrelated to the vaccine.

    Mr Covas said there had been no adverse reactions to the vaccine, and that the decision to suspend the trial had caused "outrage".

    The communication media say police are investigating the death as a suicide.

    in its declaration allowing the resumption of the trial on Wednesday, Anvisa said it now had more details about the nature of the "adverse incident".

    it said its decision to suspend judgment "known data were taken into account by the agency at the time."

    pause in a clinical trial is not unusual. In September, the UK pause trials for another Covid-19 vaccine after a participant had a suspected adverse reaction. Trials of the vaccine is being developed by AstraZeneca and they Oxford University resumed a few days after regulators said it was safe to continue.

    in October, a review of the death of a Brazilian volunteer involved in AstraZeneca trial found no safety problems. The BBC understands that the volunteer did not receive the vaccine.

    The president of Brazil has been open about his preference for the vaccine is being developed by AstraZeneca, saying his government would not buy Chinese-made vaccine Covid-19. Related topics

  • Brazil
  • coronavirus pandemic
  • vaccine development coronavirus
  • China
  • vaccination


    Image of How to find a teaching job in Universities in China
    Rate and Comment
    Image of China's Xinjiang posts foreign trade growth in Jan.-Aug.
    China's Xinjiang posts foreign trade growth in Jan.-Aug.

    Urumqi, September 20 (Xinhua) - China Northwestern China Autonomous Region of Xinjiang registered around 97.4 billion yuan (around 15.06 billion doll

    Read more →

  • Login

     

    Register

     
    Already have an account? Login here
    loader

    contact us

     

    Add Job Alert